Søgeresultater - Adam Kashishian

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo.

    Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo. af Adam Kashishian, Andrius Kazlauskas, Jonathan A. Cooper

    Udgivet 1992
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  2. 2
    GTPase-activating protein and phosphatidylinositol 3-kinase bind to distinct regions of the platelet-derived growth factor receptor beta subunit.

    GTPase-activating protein and phosphatidylinositol 3-kinase bind to distinct regions of the platelet-derived growth factor receptor beta subunit. af Andrius Kazlauskas, Adam Kashishian, Jonathan A. Cooper, Mindaugas Valius

    Udgivet 1992
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor.

    Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor. af Riko Nishimura, W Li, Adam Kashishian, Anna Mondino, Min Zhou, Jonathan A. Cooper, Joseph Schlessinger

    Udgivet 1993
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    AKAP79 Inhibits Calcineurin through a Site Distinct from the Immunophilin-binding Region

    AKAP79 Inhibits Calcineurin through a Site Distinct from the Immunophilin-binding Region af Adam Kashishian, Monique Howard, Christine Loh, W. Michael Gallatin, Merl F. Hoekstra, Yvonne Y. Lai

    Udgivet 1998
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    PI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma

    PI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma af Sarah Meadows, Francisco Vega, Adam Kashishian, Dave Johnson, Volker Diehl, Langdon L. Miller, Anas Younes, Brian J. Lannutti

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor.

    Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor. af Robert J. Lechleider, Satoru Sugimoto, Anton M. Bennett, Adam Kashishian, Jonathan A. Cooper, Steven E. Shoelson, Christopher T. Walsh, Benjamin G. Neel

    Udgivet 1993
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    p110δ, a Novel Phosphatidylinositol 3-Kinase Catalytic Subunit That Associates with p85 and Is Expressed Predominantly in Leukocytes

    p110δ, a Novel Phosphatidylinositol 3-Kinase Catalytic Subunit That Associates with p85 and Is Expressed Predominantly in Leukocytes af David Chantry, Anne B. Vojtek, Adam Kashishian, Douglas A. Holtzman, Christi L. Wood, Patrick W. Gray, Jonathan A. Cooper, Merl F. Hoekstra

    Udgivet 1997
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  8. 8
    DNA-Dependent Protein Kinase Is a Molecular Target for the Development of Noncytotoxic Radiation–Sensitizing Drugs

    DNA-Dependent Protein Kinase Is a Molecular Target for the Development of Noncytotoxic Radiation–Sensitizing Drugs af Eric T. Shinohara, Ling Geng, Jiahui Tan, Heidi Chen, Yu Shir, E. Edwards, James Halbrook, Edward A. Kesicki, Adam Kashishian, Dennis E. Hallahan

    Udgivet 2005
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    Targeting Nonclassical Oncogenes for Therapy in T-ALL

    Targeting Nonclassical Oncogenes for Therapy in T-ALL af Prem S. Subramaniam, Dosh Whye, Evgeni Efimenko, Jianchung Chen, Valeria Tosello, Kim De Keersmaecker, Adam Kashishian, Mary Ann Thompson, Mireia Castillo‐Martin, Carlos Cordón-Cardo, Utpal P. Davé, Adolfo A. Ferrando, Brian J. Lannutti, Thomas G. Diacovo

    Udgivet 2012
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  10. 10
    CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability

    CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability af Brian J. Lannutti, Sarah Meadows, Sarah E.M. Herman, Adam Kashishian, Bart Steiner, Amy J. Johnson, John C. Byrd, Jeffrey W. Tyner, Marc Loriaux, Mike Deininger, Brian J. Druker, Kamal D. Puri, Roger G. Ulrich, Neill A. Giese

    Udgivet 2010
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: